A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin)

A comparative debate on the various anti-vascular endothelial growth factor drugs: Pegaptanib sodium (Macugen), ranibizumab (Lucentis) and bevacizumab (Avastin)

Wet age-related macular degeneration and diabetic retinopathy are pathological consequences of vascular endothelial growth factor (VEGF) release as a reaction to deficiency of oxygen and nutrients in the macular cells. Conventional treatment modalities have been constrained by limited success. Convi...

Full description

Bibliographic Details
Main Authors: Nagpal Manish, Nagpal Kamal, Nagpal P
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2007-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Angiogenesis
diabetic retinopathy
vascular endothelial growth factor
wet age-related macular degeneration
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2007;volume=55;issue=6;spage=437;epage=439;aulast=Nagpal

Similar Items

Similar Items